ciprofloxacin has been researched along with Bacteroides Infections in 9 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Bacteroides Infections: Infections with bacteria of the genus BACTEROIDES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After induction of experimental polymicrobic osteomyelitis with Staphylococcus epidermidis and Bacteroides thetaiotaomicron (ciprofloxacin MIC, 0." | 7.68 | Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron. ( Gill, LR; Hossler, FE; Lambe, DW; Mayberry-Carson, KJ; Tober-Meyer, B, 1990) |
| "Difloxacin (A-56619) and A-56620, two novel fluoroquinolones, were tested in comparison with ciprofloxacin, cefoxitin, and combined clindamycin and gentamicin in the treatment of experimentally induced intraabdominal abscess associated with Bacteroides fragilis." | 7.67 | Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess. ( Chuah, SK; Gollapudi, SV; Thadepalli, H, 1986) |
| "Treatment with ciprofloxacin at 0." | 5.27 | Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. ( Bloom, R; Fu, KP; Gregory, FJ; Hung, PP; Vince, T, 1987) |
| "After induction of experimental polymicrobic osteomyelitis with Staphylococcus epidermidis and Bacteroides thetaiotaomicron (ciprofloxacin MIC, 0." | 3.68 | Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron. ( Gill, LR; Hossler, FE; Lambe, DW; Mayberry-Carson, KJ; Tober-Meyer, B, 1990) |
| "Difloxacin (A-56619) and A-56620, two novel fluoroquinolones, were tested in comparison with ciprofloxacin, cefoxitin, and combined clindamycin and gentamicin in the treatment of experimentally induced intraabdominal abscess associated with Bacteroides fragilis." | 3.67 | Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess. ( Chuah, SK; Gollapudi, SV; Thadepalli, H, 1986) |
| "Treatment with ciprofloxacin at 0." | 1.27 | Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. ( Bloom, R; Fu, KP; Gregory, FJ; Hung, PP; Vince, T, 1987) |
| "Ciprofloxacin was 1 to 3 twofold dilutions more active than A-61827 against these gram-negative bacteria." | 1.27 | A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. ( Bower, RR; Chu, DT; Fernandes, PB; Hanson, CW; Hardy, DJ; Ramer, NR; Stamm, JM; Swanson, RN, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merschin, D | 1 |
| Ekkernkamp, A | 1 |
| Seifert, J | 1 |
| Vrtis, MC | 1 |
| Gollapudi, SV | 2 |
| Chuah, SK | 2 |
| Harvey, T | 1 |
| Thadepalli, HD | 1 |
| Thadepalli, H | 2 |
| Moody, JA | 1 |
| Fasching, CE | 1 |
| Sinn, LM | 1 |
| Gerding, DN | 1 |
| Peterson, LR | 1 |
| Santiago, M | 1 |
| Chocarro, A | 1 |
| Chaves, F | 1 |
| Sánchez-Zaballos, I | 1 |
| Mayberry-Carson, KJ | 1 |
| Tober-Meyer, B | 1 |
| Gill, LR | 1 |
| Lambe, DW | 1 |
| Hossler, FE | 1 |
| Fu, KP | 1 |
| Vince, T | 1 |
| Bloom, R | 1 |
| Gregory, FJ | 1 |
| Hung, PP | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Swanson, RN | 1 |
| Ramer, NR | 1 |
| Hanson, CW | 1 |
| Bower, RR | 1 |
| Stamm, JM | 1 |
| Hardy, DJ | 1 |
1 review available for ciprofloxacin and Bacteroides Infections
| Article | Year |
|---|---|
Is your patient taking the right antimicrobial?
Topics: Adult; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Causality; Ciprofloxacin | 2008 |
8 other studies available for ciprofloxacin and Bacteroides Infections
| Article | Year |
|---|---|
[The Vulnerable Heel of Achilles: Intratendinous Abscess Following a Cat Bite].
Topics: Abscess; Achilles Tendon; Aged, 80 and over; Animals; Bacillaceae Infections; Bacillus; Bacteroidace | 2017 |
In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; CD4-CD8 Ratio; Cell Di | 1993 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bac | 1990 |
[Ciprofloxacin in the treatment of a case of endocarditis caused by Eikenella corrodens].
Topics: Aged; Bacteroides Infections; Ciprofloxacin; Eikenella corrodens; Endocarditis, Bacterial; Female; H | 1990 |
Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron.
Topics: Animals; Bacteroides; Bacteroides Infections; Bone and Bones; Bone Marrow; Catheters, Indwelling; Ci | 1990 |
Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Ciprofloxacin; Escherichia coli Infe | 1987 |
A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacteroides Infecti | 1988 |
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections | 1986 |